Role of ATP-sensitive K+ channel current in ischemic arrhythmias

Cardiovascular Drugs and Therapy

Volumn 7, Issue 3 Supplement, 1993, Pages 521-526

  Wilde, Arthur A M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

arrhythmias; ATP sensitive K+ channel; ischemia; potassium channel openers; sulphonylureas

Indexed keywords

ADENOSINE TRIPHOSPHATE; CROMAKALIM; GLIBENCLAMIDE; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM CHANNEL STIMULATING AGENT; POTASSIUM ION; SULFONYLUREA; TOLBUTAMIDE;

ACTION POTENTIAL; ANGINA PECTORIS; ANIMAL MODEL; ANIMAL TISSUE; ARRHYTHMOGENESIS; CARDIOVASCULAR EFFECT; CONFERENCE PAPER; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFECT; HEART ELECTROPHYSIOLOGY; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART VENTRICLE ARRHYTHMIA; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; RABBIT; RAT;

ADENOSINE TRIPHOSPHATE; ANIMAL; ARRHYTHMIA; ELECTROPHYSIOLOGY; HUMAN; MYOCARDIAL ISCHEMIA; POTASSIUM CHANNELS;

EID: 0027489241     PISSN: 09203206     EISSN: 15737241     Source Type: Journal    
DOI: 10.1007/BF00877617     Document Type: Article

References (45)

1. Über die Folgen der Kranzarterien-verschliessung für das Herz
2. Extracellular potassium accumluation in acute myocardial ischemia
3. Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction
4. Arrhythmias induced by coronary artery occlusion: What are the electrophysiological mechanisms
5. The role of catecholamines in the production of ischemia-induced ventricular arrhythmias in the rat in vivo and in vitro
6. The deleterious effects of myocardial catecholmines on cellular electrophysiology and arrhythmias during ischemia and reperfusion
7. Mechanisms contributing to malignant arrhythmias induced by ischemia in the cat
8. Anesthetized rabbit as a model for ischemia- and reperfusion-induced arrhythmias
9. Reentrant and non-reentrant mechanisms contribute to arrhythmogenesis during early myocardial ischemia: Results using three dimensional mapping
10. Distribution of extracellular potassium and its relation to electrophysiological changes during acute myocardial ischemia in the isolated perfused porcine heart
11. Antidiabetic sulphonylureas control action potential properties in heart cells via high affinity receptors that are linked to ATP-dependent K+ channels
12. Mechanism of potassium efflux and action potential shortening during ischemia in isolated mammalian cardiac muscle
13. Effects of ATP-sensitive K+ channel blockers on the action potential shortening in hypoxic and ischemic myocardium
14. Anoxic contractile failure in rat heart myocytes is caused by failure of intracellular calcium release due to alteration of the action potential
15. BRL 34195 (cromakalim) activates ATP-sensitive potassium current in cardiac muscle
16. Potassium accumulation in the globally ischemic mammalian heart: A role for the ATP-sensitive potassium channel
17. Sulphonylureas, ATP-sensitive K+ channels, and cellular K+ loss during hypoxia, ischemia, and metabolic inhibition in mammalian ventricle
18. Activation of cardiac ATP-sensitive K+ current during hypoxia: Correlation with tissue ATP levels
19. Modification by glibenclamide of the electrophysiological consequences of myocardial ischemia in dogs and rabbits
20. ATP regulated K+ channels protect the myocardium against ischemia/reperfusion damage
21. Inhibition by barium and glibenclamide of the net loss of86Rb+ from rabbit myocardium during hypoxia
22. Reduction of ischemic K+ loss and arrhythmias in rat hearts. Effect of glibenclamide, a sulphonylurea
23. Effects of glyburide on ischemia-induced changes in extracellular potassium and local myocardial activation: A potential new approach to the management of ischemia-induced malignant ventricular arrhythmias
24. Effects of glibenclamide and nicorandil on cardiac function during ischemia and reperfusion
25. Why do ischemic and hypoxic myocardium lose potassium
26. Influence of ATP-sensitive potassium modulators on ischemia-induced fibrillation in isolated rat hearts
27. Billman GE, Avendano CE, Halliwill JR, Burroughs JM. Effect of the potassium channel antagonist, glybenclamide, on sudden death: Protection from ventricular fibrillation (abstr). J Am Coll Cardiol 1991;17:165A.
28. Study of mechanisms and effects of sodium 5-hydroxydecanoate on experimental ischemic ventricular arrhythmia
29. Profibrillatory actions of pinacidil in a conscious canine model of sudden coronary death
30. Antiarrhythmic effects of nicorandil on canine cardiac Purkinje fibers
31. Electrophysiological and anti-arrhythmic effects of the K-channel opener, BRL 34915, in cardiac Purkinje fibers
32. Antiarrhythmic actions of the ATP-regulated K+ current activated by pinacidil
33. A summary of criticisms of the findings and conclusions of the University Group Diabetes Program (UGDP)
34. Effectiveness of glibenclamide on myocardial ischemic ventricular arrhythmias in non-insulin-dependent diabetes mellitus
35. Vascular complications and long-term administration of oral hypoglycemic agents in patients with diabetes mellitus
36. Cardioprotective effects of the potassium channel opener cromakalim: Stereo-selectivity and effects on myocardial adenine nucleotides
37. Anti-ischemic effects of the potassium channel activators pinacidil and cromakalim and the reversal of these effects with the potassium blocker glyburide
38. Effects of nicorandil on coronary circulation and myocardial ischemia
39. The new K+ channel opener aprikalim (RP 52891) reduces experimental infarct size in dogs in the absence of hemodynamic changes
40. Blockade of the ATP-sensitive potassium channel modulates reactive hyperemia in the canine coronary circulation